Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)

Last updated on 2023-01-19 History
Report ID 154024
Drug Identification Number 02303108
Brand name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Common or Proper name HEPARIN SODIUM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 10000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 50ML 1LIVI
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-01
Estimated end date 2023-01-13
Actual end date 2023-01-18
Shortage status Resolved
Updated date 2023-01-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2023-01-19 French Compare
v29 2023-01-19 English Compare
v28 2022-12-28 French Compare
v27 2022-12-28 English Compare
v26 2022-11-28 French Compare
v25 2022-11-28 English Compare
v24 2022-11-02 French Compare
v23 2022-11-02 English Compare
v22 2022-10-12 French Compare
v21 2022-10-12 English Compare
v20 2022-09-21 French Compare
v19 2022-09-21 English Compare
v18 2022-09-21 French Compare
v17 2022-09-21 English Compare
v16 2022-08-18 French Compare
v15 2022-08-18 English Compare
v14 2022-08-03 French Compare
v13 2022-08-03 English Compare
v12 2022-07-06 French Compare
v11 2022-07-06 English Compare

Showing 1 to 20 of 30